No Guts No Glory Probiotics

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Patients Using Olanzapine, Quetiapine, Risperidone or Clozapine

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

KieN VIP Leeuwarden, Leeuwarden, Provincie Friesland, Netherlands
Contact: Study coordinator (Marrit Wiersma) · marrit@kien.nu · +31614734656
Contact: Study coordinator (Hesra Bijen) · bijenhesra@gmail.com · +31614734656
Contact: Principal Investigator (Nynke Boonstra, PhD)
University Medical Center Groningen, Groningen, Provincie Groningen, Netherlands
Contact: Study coordinator (Toon A.W. Scheurink, MSc) · a.w.scheurink@umcg.nl · +31681528283
Contact: Principal Investigator (Iris E.C. Sommer, MD, PhD)
Antes Parnassia Groep, Rotterdam, South Holland, Netherlands
Contact: Study coordinator (Yunus A.W. Yalcin, PhD) · y.yalcin@parnassiagroep.nl · +310613434115
Contact: Principal Investigator (Nico van Beveren, MD, PhD)

Study leads

Iris E.C. Sommer, Prof. Dr.
Principal Investigator
University Medical Center Groningen

View source on ClinicalTrials.gov